GIM Fellowship Concentration in Pharmacoepidemiology
General Internal Medicine fellow applicants are welcome to consider the NHLBI-funded pharmacoepidemiology training program that is hosted by the Johns Hopkins Bloomberg School of Public Health.
All supported trainees work with core faculty on existing or newly developed research projects on pharmacoepidemiology, so as to optimize the safe and effective use of medicines to treat heart, lung and blood diseases in the United States. The aim of the program is to train the next generation of scientists to address the needs of patients, clinicians, payers, regulators and other stakeholders, and in so doing, improve the optimal use of medicines to treat heart, lung and blood diseases in the United States.
Postdoctoral fellows will participate in on-going and fellow-initiated research addressing medication and device utilization, effectiveness, and safety relevant to health, lung, and blood diseases. They acquire special expertise in conducting pharmacoepidemiology research in their specialty discipline under the guidance of a mentor. Please visit the Center for Drug Safety and Effectiveness website for more information about our faculty and trainees.